European Neuroendocrine Tumor Society

European Neuroendocrine Tumor Society

Open Access statistics for European Neuroendocrine Tumor Society, Germany, covering academic research published from 2001 to 2023.

Open Access statistics for European Neuroendocrine Tumor Society, Germany, covering academic research published from 2001 to 2023. Read More.


Open Access Percentage

37%


Total
Publications

559


Total Open
Publications

209


Total
Citations

4.8K


Open Access
Percentage

37%


Total
Publications

559


Total Open
Publications

209


Total
Citations

4.8K

Website

download

Breakdown

15% 16% 6% 63%

Publisher Open

15%

Both

16%

Other Platform Open

6%

Closed

63%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

010203040506070Total Publications
20012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

21%OA Journal

OA Journal 21%

38

Hybrid 44%

77

No Guarantees 35%

61

Other Platform Open

Domain 65%

81

Institution 47%

59

Preprint 30%

37

Other Internet 18%

23

Public 2%

3

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
73
Research Square
Preprint
44
Europe PMC
Domain
32
Würzburg University - Online Publication Service of Würzburg University
Institution
18
Augsburg University - OPUS - Augsburg University Publication Server
Institution
11
Unknown Repository
Other Internet
10
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System
Institution
6
ZB MED - Informationszentrum Lebenswissenschaften - PUBLISSO-Fachrepositorium Lebenswissenschaften
Other Internet
5
Royal Academy of Art and Sciences (KNAW) - KNAW research portal
Institution
5
Ludwid Maxmilian's Universitat Munchen - Open access LMU
Institution
5
1 / 6

Data updated 7 October 2024

Share

Share

Share